Natus Medical today announced it completed the previously announced acquisition of Micromed Holdings.
The deal, announced in December 2022, will add Micromed’s neurophysiology solutions to Natus Medical’s offerings. The financial details of the acquisition were not disclosed.
The Micromed acquisition is the first transaction made by the Middleton, Wisconsin-based company since its $1.2 billion acquisition by the ArchiMed group in July 2022.
“We are thrilled to complete this deal and move forward combining the Natus and Micromed teams and product portfolios,” Natus President Austin Noll said in a news release. “Together, we will be able to provide our neuroscience customers a more comprehensive product offering and unrivaled global service and support through the increased breadth and depth of our combined resources.”
Natus Medical has specialized in 85 years of neurodiagnostic leadership. Micromed’s portfolio of electroencephalography, polysomnography, electromyography and intensive care unit monitoring will add to that.
“The Micromed team is excited to bring our passion, our experience, our products and our European leadership to Natus,” GM of Micromed Cristiano Rizzo said. “As we expand through the extensive Natus structure, we will continue to cultivate the customer and key opinion leader relationships that we have established at Micromed over the years.”